Management of Patients with Graves’ Disease and Orbital Involvement: Role of Spectral Domain Optical Coherence Tomography
Table 1
GO patients versus controls: demographics and baseline clinical characteristics.
Variable
GO patients
Controls
value
Age (years)
44.1 ± 9.8
44.2 ± 10.7
1.0
Gender (male/female)
8/10
7/11
1.0§
Axial length (mm)
23.9 ± 0.8
24.0 ± 1.4
0.7
Spherical equivalent (diopters)
−0.6 ± 1.3
−0.4 ± 1.7
0.5°
Intraocular pressure (mmHg)
14.0 ± 1.9
13.4 ± 1.6
0.2°
BCVA (number of ETDRS letters)
61.9 ± 2.3
62.3 ± 2.1
0.4
Glycaemia (mg/dL)
80.8 ± 5.6
82.4 ± 6.3
0.4
LDL cholesterol (mg/dL)
82.2 ± 12.4
81.9 ± 11.9
0.9
Total cholesterol (mg/dL)
139.6 ± 13.3
132.2 ± 12.9
0.1
Systolic blood pressure (mmHg)
123.9 ± 7.1
122.8 ± 6.7
0.6°
Diastolic blood pressure (mmHg)
71.6 ± 4.2
70.8 ± 4.3
0.6°
Smoking/no smoking
12/6
9/9
0.5§
Values are mean ± SD unless otherwise indicated. Unpaired t-test with Levene’s test for equality of variances. °Mann–Whitney U test. §Fisher’s exact test.
